| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.27 | 0.09 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.1 |